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Abstract
We have defined functions of MEK in regulating gliogenesis in developing cerebral cortex using
loss and gain of function mouse genetics. Radial progenitors deficient in both Mek1 and Mek2 fail
to transition to the gliogenic mode in late embryogenesis, and astrocyte and oligodendroglial
precursors fail to appear. In exploring mechanisms, we found that the key cytokine regulated
gliogenic pathway is attenuated. Further, the Ets transcription family member Etv5/Erm is
strongly regulated by MEK and Erm overexpression can rescue the gliogenic potential of Mek
deleted progenitors. Remarkably, Mek1/2 deleted mice surviving postnatally exhibit cortices
almost devoid of astrocytes and oligodendroglia and exhibit neurodegeneration. Conversely,
expression of constitutively active MEK1 leads to a major increase in numbers of astrocytes in the
adult brain. We conclude that MEK is essential for acquisition of gliogenic competence by radial
progenitors, and that levels of MEK activity regulate gliogenesis in the developing cortex.
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Introduction
The RAF/MEK/ERK pathway is among the most studied signaling cascades in biology by
virtue of its critical, conserved functions in mediating the effects of extracellular factors on
cell proliferation, differentiation, and function (Cargnello and Roux, 2011; Johnson and
Lapadat, 2002). Importantly, genetic mutations in core pathway components including Mek1
(MAP2K1) and Mek2 (MAP2K2) cause cardiac, craniofacial and cutaneous abnormalities
(CFC syndrome) in humans that are invariably associated with severe cognitive impairment
(Rodriguez-Viciana et al., 2006; Samuels et al., 2009; Tidyman and Rauen, 2009).
Nonetheless, many of the critical functions of MEK in brain development have yet to be
defined.
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Due to the broad availability of inhibitors of MEK, a key node in the pathway, the
requirement for RAF/MEK/ERK signaling has been extensively studied in reduced
preparations. However, despite a myriad of effects attributed to MEK inhibition, the
functions mediated by MEK during mammalian development in vivo remain largely
uncharacterized. Recently the generation of null and floxed alleles have provided the tools
for decisive studies of the requirement of RAF/MEK/ERK signaling in key
neurodevelopmental events in mice (Fyffe-Maricich et al., 2011; Galabova-Kovacs et al.,
2008; Newbern et al., 2008; Newbern et al., 2011; Pucilowska et al., 2012; Samuels et al.,
2008; Satoh et al., 2011; Zhong et al., 2007). However, interpretation of many of the
analyses published so far has been complicated by the possibility of redundant functions of
multiple family members at each level of the cascade and early death of many of the mutant
lines.
Here we have determined the requirement for MEK in regulating gliogenesis in the
developing cortex by deleting both Mek1 and Mek2 (Mek1/2) or overexpressing
constitutively active Mek1 (caMek1) in radial progenitors at mid-embryogenesis. Radial
progenitors are a self-renewing stem cell population, giving rise to both neurons and glia
(Kriegstein and Alvarez-Buylla, 2009). Several lines of evidence have suggested key roles
for the MEK/ERK signaling cascade in the regulation of neurogenesis. An upstream
regulator of the pathway, SHP-2, is reported to be required for the proliferation of neural
progenitors and neurogenesis (Gauthier et al., 2007; Ke et al., 2007). Further, a recent study
showed a requirement for ERK2 in regulating the proliferation of neurogenic precursors
(Pucilowska et al., 2012). Finally, neurotrophin-induced differentiation of cortical neuronal
progenitors is critically dependent on a MEK-C/EBP pathway (Menard et al., 2002).
Consistent with the idea that MEK is required for neurogenesis, some studies have
suggested that MEK/ERK signaling suppresses astrocytic differentiation (Menard et al.,
2002; Paquin et al., 2005). On the other hand, in vitro studies show that FGF2, a powerful
activator of MEK/ERK signaling, induces glial fate specification and enhances
differentiation of glia induced by gliogenic signals (Morrow et al., 2001; Song and Ghosh,
2004). Moreover, analyses of Fgfr1 null mice demonstrate that FGF signaling is required for
radial glia somal translocation and the formation of specialized astroglial populations
required for commissure development (Smith et al., 2006). However, it remains unclear
whether the effects of FGF signaling on glial development in mammalian brain are mediated
by MEK/ERK, PI3K or other pathways downstream of FGF receptors. Interestingly, in
Drosophila, glial differentiation in the developing eye requires FGF/Rolled (Drosophila
MAPK) signaling acting via the Drosophila Ets transcription factor, Pointed (Franzdottir et
al., 2009). Finally, a recent study of cortical astrocytic development showed proliferation of
mature-appearing astrocytes in upper cortical layers, raising the possibility that FGFs or
other growth factors might act at more than one stage in regulating the astrocytic lineage (Ge
et al., 2012).
Genetic manipulation of MEK specifically in radial progenitors can address decisively the
role of MEK/ERK MAPK signaling in cortical gliogenesis. To achieve this goal, we
conditionally deleted Mek1/2 specifically in radial progenitors using NestinCre, hGFAPCre,
and in utero electroporation (IUE) of Cre, and assessed gain of function by introducing
caMek1 using similar methodologies. We have found that Mek1/2 deletion severely
compromises radial progenitor fate transition into a gliogenic state. Our results show a
striking reduction of glial progenitors in Mek1/2 deleted cortices and a failure of
gliogenesis. Conversely we demonstrate that caMEK1 promotes precocious glial progenitor
specification and that the effect is cell autonomous. In exploring the mechanism of the glial
specification defect, we found the key cytokine regulated gliogenic pathway is attenuated.
We further find that the Ets transcription family member Etv5/Erm is strongly regulated by
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MEK, has an expression pattern restricted to the ventricular zone (VZ) at E14, and rescues
the gliogenic potential of Mek deleted progenitors. Finally, examination of brains
postnatally in loss and gain of function mutant animals shows that numbers of glial cells in
the cortex are strongly and persistently under the control of MEK signaling. We conclude
that MEK is a key regulator of gliogenesis in the developing brain.
Results
Mek1/2 deletion leads to loss of radial glial properties
To study the function of MEK1/2 in cortical development, we bred Mek1 exon-3 floxed and
Mek2−/− mice with a NestinCre line (see supplemental references). Three-allele deletion
mutants, Mek1fl/+Mek2−/−NesCre and Mek1fl/flMek2+/−NesCre are viable and breed, though
the latter are smaller than controls. The viability of mutants with a single wild type allele of
either Mek1 or Mek2 suggests that MEK1 and MEK2 can significantly compensate for one
another in the nervous system and that deletion of four alleles is necessary for complete
elimination of pathway function.
In contrast, Mek1fl/flMek2−/−NesCre conditional mutants (referred to as Mek1,2\Nes) fail to
acquire milk and die shortly after birth. Western blots show that levels of total and
phosphorylated MEK1 protein are strongly reduced in mutant dorsal telencephalon lysates
by E11.5 (Figure S1A). To our surprise, Mek1,2\Nes mutant brains did not exhibit gross
morphological abnormalities at P0 (Figure S1B).
We assessed radial progenitor development at two stages, E13.5 and E17.5. Staining for the
radial progenitor marker, Nestin, or the neural stem cell marker, Sox2, or proliferation as
assessed by Brdu incorporation showed no major difference between E13.5 Mek1,2\Nes and
WT cortices (Figure S1C–E′). However, a conclusion that MEK is dispensable for the initial
behavior of radial progenitors should be tempered by the possible persistence of low levels
of MEK1 protein within the cells at E13.5.
By late embryogenesis, mutant radial progenitors showed striking reduction in glial-like
biochemical properties. Thus, we found dramatic reductions in the expression of RC2 and
glial glutamate transporter (GLAST) in E17.5 mutant dorsal cortices (Figure 1A–B′). These
marker reductions were not due to loss of the radial progenitor pool since immunostaining
for the transcription factor Pax6, which labels progenitor nuclei, revealed a relatively normal
pattern (Figure 1C–C′). Furthermore, electroporation of CAG (chick β-actin promoter/CMV
enhancer) driven ires-EGFP plasmid (pCAG-EGFP) into WT and mutant cortices labeled a
roughly comparable number of radial glia with grossly normal morphology including
processes reaching the pial surface (Figure 1D–D′). Finally, we did not observe major
changes in proliferation or survival as assessed by immunostaining of E17.5 cortices for
phosphorylated histone-3 and activated caspase-3 (data not shown). Indeed mutant radial
progenitors continued to generate neurons (See below). In summary, our studies indicate
that Mek1/2 inactivation leads to a failure in the maintenance of glial-like properties of
radial progenitors at late embryonic stages.
Mek1/2 deletion blocks glial progenitor specification
During late embryogenesis, radial progenitors undergo a transition from a neurogenic to a
gliogenic mode. Since MEK clearly regulated glial characteristics of late embryonic radial
progenitors, we tested whether the production of astrocyte and oligodendrocyte progenitors
was affected. We analyzed the expression of multiple glial progenitor markers in E18.5-P0
brains. Tenascin C, an extracellular matrix glycoprotein secreted by astrocytes, was found to
be dramatically reduced in E18.5 Mek1,2\Nes cortex (Figure 2A–A′). In P0 WT cortices,
brain lipid binding protein (BLBP) immunolabeling revealed numerous astrocytic precursors
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in the developing dorsal cortical wall. In Mek1,2\Nes dorsal cortices, these BLBP+ soma
were almost entirely absent, further documenting the failure in formation of astrocytic
precursors (Figure 2B–C′). We confirmed the loss of astrocyte precursors by western
blotting for the pan-cortical astrocyte marker aldehyde dehydrogenase 1 family member L1
(Aldh1l1) and grey matter astrocyte marker Acyl CoA Synthetase bubblegum family
member 1(Acsbg1)(Cahoy et al., 2008) in lysates of P0 control and mutant cortices (Figure
2F).
MEK was also required for the appearance of oligodendrocyte progenitor cells (OPCs).
Thus, immunostaining for Olig2 and PDGFRα showed nearly complete loss of OPCs in
Mek mutant dorsal cortices (Figure 2D–E′). Finally, microarray analyses of E18.5 WT and
Mek1,2\Nes dorsal cortices further confirmed marked and specific decreases in a number of
genes expressed in astrocyte precursors and OPCs (Figure 2G and Table 1). Besides glial
related markers, we also found a dramatic reduction of Egfr mRNA in the mutant cortices
(Table 1). EGFR was previously shown to play a critical role in determining progenitor
gliogenic fate and gliogenesis (Sun et al., 2005; Viti et al., 2003). In contrast, expression of
neuronal genes MAP2 and βIII-tubulin was not altered. These results demonstrate that MEK
is necessary for radial progenitors to transition to the gliogenic mode.
Since Mek1/2 mutant radial progenitors failed to differentiate into glial progenitors, we
reasoned that mutant progenitors may remain in the neurogenic mode and continue to
produce neurons. To test this hypothesis, we performed Brdu birthdating analysis at E17.5
and found an increase in neurogenesis in the mutant cortex. Co-labeling of Brdu and Cux1
showed a 42% increase in upper layer neuron production in E17.5 Mek1,2\Nes cortex
(Figure S2A–E). These data suggest that MEK signaling is required for radial progenitors to
exit the neurogenic mode. We also noticed a delayed migration of these late born neurons.
Quantification showed 70% of neurons born in E17.5 WT cortex migrate to upper cortical
layers (bin1–2) by P0, while only 54% of E17.5-born neurons migrate to the upper cortical
layers in the mutant mice (Figure S2F). This migration delay could be secondary to the
delayed birthday of the neurons or to a failure in the maintenance of important RG
properties.
MEK functions are cell autonomous and instructive
To determine if the failure of glial progenitor specification is cell autonomous, we
performed mosaic loss of MEK function by electroporating pCAG-EGFP or pCAG-Cre-
EGFP plasmids into E15.5 Mek1fl/fl Mek2−/− radial progenitors, followed by organotypic
cortical slice culture for 4 days. We then assessed the proportion of transfected cells that
coexpressed the astrocyte precursor marker, BLBP. After transfection of EGFP, we found
that 6.13±0.44% of transfected cells expressed BLBP. In contrast, after transfection of Cre,
only 1.15±0.29% of transfected cells were BLBP+ (Figure S3A–C). This result suggests that
MEK plays a cell autonomous role in regulating glial progenitor specification.
Our results strongly indicated that MEK is required for gliogenesis, however, it was unclear
whether overactivation of MEK was sufficient to drive gliogenesis. We tested this by
introducing pCAG-caMek1-EGFP into E15.5 WT radial progenitors by IUE and quantifying
the proportion of transfected cells that express BLBP at E19.5. In EGFP transfected cortices,
5.68±0.94% of transfected radial progenitors became astrocyte precursors. In caMek1
transfected cortices, the proportion of radial progenitors that became astrocyte precursors
increased robustly to 24.78±2.07% (Figure 3A–C).
In additional experiments, we assessed the ability of caMek1 to convert radial progenitors
into mature astrocytes by allowing mice electroporated at E15.5 to survive until P60.
Normally, electroporation of EGFP at E15.5 results in robust labeling of neurons in layer II–
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III with virtually no astrocytes labeled. In striking contrast, transfection of caMek1 results in
multiple mature astrocytes labeled in every section (Figure 3D–E). The astrocyte identity is
confirmed by Acsbg1 immunostaining (Figure S3D–E). Overall, approximately 50% of
labeled cells were astrocytes. Intriguingly, labeled neurons occupied a very superficial
position in layer II consistent with overactive MEK stimulating accelerated progression of
radial progenitor development (see below).
Taken together, these data suggest that the regulation of glial progenitor specification by
MEK is cell autonomous and demonstrate that MEK is both necessary and instructive for
glial specification.
Deletion of Mek1/2 impairs gliogenic signaling
To assess the mechanisms by which MEK regulates glial progenitor specification, we
examined the response of Mek deleted cortical cells to a gliogenic stimulus in vitro.
Cytokine signaling through the LIFRβ/gp130-JAK-STAT pathway is a critical stimulus for
astrocyte differentiation. We therefore induced astrocyte differentiation with CNTF (100ng/
ml) in WT or Mek1,2\Nes E17.5 cortical cultures. In WT cultures without CNTF, 4% of the
cells differentiated into GFAP+ astrocytes after 5 days. Adding CNTF increased astrocyte
differentiation as expected to 15%. In mutant cultures, only 1% of cells differentiated into
astrocytes without CNTF stimulation, which increased to only 2% after stimulation with
CNTF (Figure 4A–B). Confirming the cell counting, western blotting showed that the level
of GFAP protein in Mek1,2\Nes samples was only 20% of controls, while levels of the
neuronal marker βIII-tubulin were comparable to controls (Figure 4C–D).
The STAT3 Tyrosine 705 site is directly phosphorylated by the upstream kinase JAK
following CNTF stimulation (Liu et al., 1998). Importantly, STAT3 phosphorylation on
Tyrosine 705 was dramatically reduced in mutant cultures, indicating that the CNTF
gliogenic pathway is impaired (Figure 4C–D). The reduction of tyrosine phosphorylation is
not likely due to a direct link between MEK signaling and STAT3. To better understand the
interaction between MEK and CNTF signaling, we examined the expression levels of the
major components in CNTF pathway. We found that the expression of gp130, the co-
receptor for CNTF, was dramatically attenuated, thus hindering gliogenic signaling at the
first step of the cascade (Figure 4C–D). These results demonstrate that the requirement for
MEK is cell autonomous and that Mek mutant progenitors fail to acquire gliogenic
competence.
Erm promotes glial progenitor specification
We interrogated our microarray data set from E18.5 Mek1,2\Nes cortices to identify
candidate transcription factors downstream of MEK that may mediate glial progenitor
specification. We noted a profound decrease in the expression of the Ets transcription factor
family member-Ets related molecule (Etv5/Erm) (Figure 5A). Erm is a promising candidate
to regulate glial development as PEA-3 family member transcription factors are known
FGF/MAPK targets with multiple roles in the regulation of nervous system development.
In-situ hybridization was performed to visualize Erm expression in WT and mutant brains.
Remarkably, we found that Erm is intensely expressed in the WT VZ at E14.5 (Figure 5B,
arrows), which correlates with the enriched phosphorylated-ERK1/2 in the VZ at this stage
(Pucilowska et al., 2012; Seuntjens et al., 2009). At E18.5, Erm continues to be expressed in
the WT VZ (Figure 5C, arrows) and is also expressed in deep cortical layers. Strikingly,
Erm expression in the VZ was profoundly reduced in both E14.5 and E18.5 Mek1,2\Nes
cortices (Figure 5B′ and 5C′). Interestingly, Erm expression was maintained in the deep
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cortical layers of mutant cortices, suggesting that MEK regulation of Erm expression is
specific to radial progenitors.
To test whether Erm plays a role in glial progenitor specification, we overexpressed Erm by
IUE of a pCAG-Erm-GFP plasmid into E15.5 dorsal cortical radial progenitors. The
proportion of EGFP and GLAST co-expressing astrocyte precursors was then assessed at
E19.5. We found overexpression of Erm led to a 3.4 fold increase in the proportion of cells
that became GLAST+ astrocyte precursors when compared to cells transfected with EGFP
alone (Figure S4A–B). In addition, many more Erm expressing cells were present in the VZ/
SVZ, possibly due to impaired neurogenesis.
These results indicate that Erm is instructive for the specification of astrocyte precursors. To
assess whether these precursors overexpressing Erm further differentiate into mature
astrocytes, we allowed some animals to survive until P22. In contrast to cortices
electroporated with pCAG-EGFP at E15, which display no labeled astrocytes (Figure S4C),
Erm overexpression induced the formation of large numbers of astrocytes (20% of
transfected cells) (Figure 5D–D′, 5G and Figure S4C′). Further, colabeling with Acsbg1
confirmed the astrocyte identity (Figure 5E–F).
To explore whether Erm is a major transcriptional mediator of MEK signaling on
gliogenesis, we expressed Erm in Mek1,2\Nes mutant progenitors to determine whether Erm
is able to rescue the gliogenic defect. Because Mek mutant mice die at early postnatal stages,
electroporations were performed ex vivo and cortices dissociated so that astrogenesis could
be induced by CNTF. We introduced pCAG-Erm-EGFP into mutant progenitors at E14.5,
the same time point at which expression was dramatically downregulated in vivo in Mek
mutants. Although induction of astrogenesis by CNTF is less efficient at this early stage than
at E17.5, numerous GFAP positive cells can be observed in WT cultures 5 days after
addition of CNTF (100ng/ml) (Figure 5H). Consistent with the lack of gliogenesis in E17.5
Mek1,2\Nes mutant cultures (Figure 4), E14.5 mutant progenitors did not differentiate into
astrocytes in the presence of CNTF stimulation (Figure 5I). Strikingly, expression of Erm
largely rescued astrocyte number in the mutant cultures (Figure 5J–M). This result
demonstrates that Erm mediates MEK regulation of CNTF-induced astrogenesis.
To further test whether Erm is required for MEK mediated gliogenesis, we co-electroporated
dominant negative Erm (DN-Erm) with caMek1-EGFP into E14.5-E15.5 WT progenitors to
explore whether DN-Erm could inhibit caMEK1 induced astrocyte differentiation. The DN-
Erm plasmid contains the Ets domain of Erm but lacks the transcription activation domain
(Hasegawa et al., 2004). Consistent with our in vivo results (Figure 3E), caMek1
overexpression dramatically increased astrocyte number to 2.5 fold that in EGFP-transfected
cultures. Strikingly, expression of DN-Erm and caMek1 together abolished the ability of
caMEK1 to induce astrogenesis (Figure S4D–G). Western blotting of GFAP protein
confirmed that DN-Erm blocked caMEK1 induced astrocyte differentiation (Figure S4H).
In conclusion, our results demonstrate that MEK regulates Erm expression in radial
progenitors and that Erm is an important transcriptional mediator of MEK regulated
gliogenesis.
Mek1/2 deletion disrupts the generation of key midline glial populations
To confirm that the loss of MEK signaling in radial progenitors leads to a failure in the
appearance of mature glia, we analyzed the development of specific early appearing glial
populations in vivo. Though Mek1,2\Nes mutant mice die before the main wave of
astrogenesis begins, we were able to analyze the formation of earlier born astrocytes along
the cortical midline. In WT brains, GFAP staining labels three populations of midline
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astroglia at P0; the astroglia-indusium griesium (IG), the glial wedge and midline zipper glia
(MZG) (Figure 6A). Strikingly, astroglia cells in IG and MZG were completely missing
(arrows) in mutant cortex and the glial wedge did not form normally (Figure 6B).
As it is known that midline astroglia are critical for commissural axons to cross midline
(Paul et al., 2007), we performed L1 (N-CAM) immunostaining to visualize the major axon
tracts in the brains of P0 mice. We observed that two dorsal telencephalic commissures, the
corpus callosum and hippocampal commissure, did not cross the midline between the two
hemispheres in the Mek1,2\Nes brains (Figure 6B and data not shown). Instead the callosal
axons formed Probst bundles, a hallmark of callosal agenesis. This phenotype exhibited
complete penetrance. These data provide additional evidence for a glial specification defect
in Mek deficient dorsal cortices.
Mek1/2 deletion results in a persistent failure of gliogenesis
The early lethality of Mek1,2\Nes mice did not allow us to test the possibility that
gliogenesis was simply delayed rather than prevented. To generate a mutant model that
survives into the postnatal period, we utilized the hGFAPCre line, which recombines later
(E12.5) than NesCre in dorsal telencephalic progenitors (Anthony and Heintz, 2008).
Importantly, Mek1,2\hGFAP mutants survive until P10. The mutant brains appear grossly
normal at birth but were dramatically smaller than controls by P10 (Figure 7C). Consistent
with findings in Mek1,2\Nes mutants, the generation of BLBP+ astrocyte precursors and
PDGFRα+ OPCs were severely suppressed in E19.5 Mek1,2\hGFAP dorsal cortices (Figure
S5A–B′). GFAP strongly labels astrocytes in the white matter at postnatal stages, while
Acsbg1 staining labels gray matter astrocytes. In P3 mutant dorsal cortices, both Acsbg1+
and GFAP+ astrocytes were nearly absent (Figure S5C–C′). At P10, the loss of Acsbg1+
astrocytes was clearly persistent in mutant dorsal cortices and there was a profound decrease
in MBP labeling in the corpus callosum (Figure 7A′ and 7B′). Western blotting at P10
further confirmed dramatic and persistent reductions of Acsbg1 and MBP protein in mutant
dorsal cortices (Figure 7D).
Coincident with the persistent failure of gliogenesis, the mutant cortex was dramatically
reduced in size (Figure 7C). Neurodegeneration was apparent and likely due to lack of glia
support, as no degeneration was observed when Mek is specifically deleted in neurons (data
not shown). These findings strongly suggest that gliogenesis is permanently blocked in the
absence of MEK signaling and that cortical neurons require glial support for survival.
In order to rule out the possibility that deletion of Mek1/2 merely reduces glial marker
expression without affecting glial specification, we electroporated pCAG-EGFP construct
into radial progenitors at postnatal day 0–1 and assessed the cell fate over 7 days. As
recently reported (Ge et al., 2012), EGFP-expressing cells with a clear astrocyte morphology
that expressed Acsbg1, were readily observed in deeper cortical layers (Figure 7E–G and
data not shown). In contrast, in Mek deleted cortices, mature astrocytes were not observed
after electroporation at P0–1(Figure 7H–I). Many transfected cells in controls and Mek
mutants remained in the SVZ. Among the proportion of cells that migrated out to the
cortical plate, in controls 97% of transfected cells (total 115 cells) exhibited a clear astrocyte
morphology, whereas in mutants, 80% of labeled cells (total 92 cells) were NeuN+ neurons
which were rarely observed in WT (Figure 7E–G and Figure S6A–D). The remaining 19.6%
in the mutant cortex were non-neuronal cells near the SVZ border that exhibited an
abnormal morphology (Figure 7H–I).
To further assess cellular morphologies in Mek deleted brains, we injected an Adeno-
associated virus expressing EGFP (AAV-EGFP (serotype 9)) intraventricularly at P0 to label
astrocytes in vivo. We found that AAV9 labeled both neurons and astrocytes when delivered
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intraventricularly at an early postnatal stage. In WT cortices, AAV-EGFP labeled numerous
astrocytes that co-expressed Acsbg1, while in Mek1,2\hGFAP cortices, virtually no cells
with a typical astrocytic morphology were visualized (Figure S6E–E′). The few AAV-GFP
labeled non-neuronal cells did not exhibit a typical cortical astrocyte morphology (Figure
S6F–F′), failed to elaborate extensive processes, and resembled the aberrant non-neuronal
cells labeled after electroporation at P0 (Figure 7I).
We also examined the effect of Erk1/2 deletion in gliogenesis. Loss of radial progenitor
markers was noted previously in Erk1,2\NesCre mice (Imamura et al., 2010). Erk1,2\hGFAP
mutants qualitatively phenocopy Mek1,2\hGFAP mutants in glial development as expected.
Thus, we observed that Acsbg1+ staining was markedly reduced in P20 Erk1,2\hGFAP
mutant brains compared to controls (Figure S6 G–G′). However, we consistently observed
that Erk1,2\hGFAP survived roughly a week longer than Mek mutants. Further, some
mutant phenotypes (e.g. absence of corpus collosum in NesCre deleted mutants, data not
shown) were more variable than in Mek mutants. The milder phenotype exhibited by the Erk
mutants may be due to a relatively delayed recombination of Erk2 floxed allele or delayed
protein degradation in comparison to that observed in Mek mutant mice, although other
explanations are possible (see discussion).
Levels of MEK activation regulate glial number
To assess whether enhanced MEK signaling might lead to increased number of glia in the
postnatal brain, we crossed the CAG-loxpSTOPloxp-Mek1S218E,S222E line (Krenz et al.,
2008) with hGFAPCre (referred to as caMek1\hGFAP) in order to hyperactivate MEK
signaling in radial progenitors. Strikingly, MEK hyperactivation in radial progenitors leads
to a marked increase in the production of astrocyte precursors and mature astrocytes. We
found a more than two fold increase of BLBP+ astrocyte precursor number in
caMek1\hGFAP dorsal cortex at E19.5 (Figure 8A–A′ and 8F). Coincident with the
increased astrocyte precursor production, neuron numbers in caMek1\hGFAP dorsal cortex
were significantly reduced (Figure 8E–E′ and 8H). This reduced neurogenesis is consistent
with the idea that hyperactive MEK accelerates radial progenitor progression into a
gliogenic mode and prematurely terminates neurogenesis.
We also observed a major increase in the number of astrocytes in mature brain as manifested
by increases in the numbers of Acsbg1 and GFAP-labeled cells at P40 (Figure 8B–D′ and
8G). We further found that MBP staining was strikingly enhanced throughout all cortical
layers in caMek1\hGFAP mice (Figure S 7A–B′), indicating changes in oligodendrocyte
production (Fruttiger et al., 1999), MBP levels (Ishii et al., 2012) or both. The increase in
GFAP-labeled cells was particularly remarkable. GFAP+ astrocytes are normally restricted
to white matter in mature WT mice. In caMek1\hGFAP dorsal cortices, GFAP+ cells filled
the entire cortex occupying both grey and white matter (Figure 8C–C′). Further, we noted a
major increase in the number of Ki67+ astrocytes in postnatal day 10 cortices in the
caMek1\hGFAP mice (Figure S 7D–E). Thus, the increased astrocyte number observed in
mature mice is likely due to both an increase in the number of radial progenitors that
committed to the astrocytic lineage and further proliferation of astrocyte precursors/
astrocytes postnatally.
Discussion
We have demonstrated that MEK signaling strongly regulates the generation of glia from
radial progenitors in developing cortex. This conclusion is based on multiple clear-cut in
vivo findings in genetically-induced loss and gain of function models. First, glial-like
properties of radial progenitors are not maintained in Mek deleted mice and glial
specification is almost completely blocked. Second, expression of Cre or caMek1 in
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individual radial progenitors suggests that functions of MEK are cell autonomous and can be
instructive. Third, Mek deletion leads to a persistent loss of gliogenic competence as
Mek1,2\hGFAP mutants are nearly devoid of astrocytes and oligodendrocytes in the dorsal
cortex at postnatal stages. Finally, expression of caMek1 in radial progenitors leads to a
major increase in numbers of cortical astrocytes in mature mice. Our data establish MEK as
a key regulator of gliogenesis in developing mammalian cortex.
MEK signaling regulates acquisition of gliogenic competence
In developing cortex, radial progenitors first generate neurons to form neuronal circuits, and
then generate matching numbers of glial cells (Guillemot and Zimmer, 2011). Multiple
studies have demonstrated that extrinsic factors such as Notch and BMP stimulate
progenitors to become gliogenic (Gaiano and Fishell, 2002; Nakashima et al., 1999b;
Rowitch and Kriegstein, 2010). Interestingly, many of these gliogenic cues are present at
early neurogenic stages but do not induce gliogenesis (Molne et al., 2000; Takizawa et al.,
2001). An idea that has emerged is that radial progenitors undergo a cell fate switch at the
gliogenic stage making them competent to respond to gliogenic signals (Molne et al., 2000;
Song and Ghosh, 2004; Viti et al., 2003). We suggest that MEK/ERK MAPK signaling
mediates this switch from neurogenic to gliogenic competence.
ERK MAPK signaling has been implicated previously in cell fate switching. For example,
FGF4 activation of the ERK pathway is the major differentiation signal for mouse ES cells
(Kunath et al., 2007; Ying et al., 2008). Further, an important recent report demonstrated
that FGF10 determines the timing of the transition from neural epithelium to radial
progenitor, a key event in neurogenesis (Sahara and O’Leary, 2009). Our study does not
assess the role of MEK in mediating the FGF10 effect since recombination in our study
occurred after the neural epithelium stage. However, our finding that Mek deletion prevents
an important step in radial progenitor fate transition in late embryogenesis clearly has
parallels with the FGF10 result at an earlier stage in radial progenitor development.
Importantly, FGFs have previously been implicated in glial development (Naruse et al.,
2006; Seuntjens et al., 2009; Song and Ghosh, 2004). We suggest that FGF effects on
regulating radial progenitor fate transitions are mediated via MEK/ERK signaling.
Our findings provide strong evidence for an important interaction between MEK signaling
and the CNTF/LIFRβ-gp130/JAK-STAT cascade, a major cytokine signaling pathway that
promotes astrogenesis (Bonni et al., 1997). It has been well established that an increase in
the gp130 expression level in radial progenitors at mid-embryogenesis is vital for initiating
astrogenesis (He et al., 2005; Nakashima et al., 1999a). Importantly, we have demonstrated
here that MEK was required for the expression of gp130 by radial progenitors.
Consequently, CNTF failed to induce STAT3 phosphorylation and GFAP expression
efficiently in Mek1,2\Nes mutant progenitor cultures. Our data suggest MEK and CNTF/
JAK-STAT pathways work contiguously in regulating astrogenesis. Thus, MEK signaling
promotes gliogenic fate transition by radial progenitors, and then CNTF/JAK-STAT
signaling induces further differentiation of astrocyte precursors.
Progression along the oligodendrocyte lineage was also profoundly affected by Mek
deletion. In line with our results, partial inhibition of ERK/MAPK signaling by deletion of
Braf or Erk2 has previously been shown to inhibit CNS myelination, though the effect on
radial progenitor fate transition to OPC was unclear (Fyffe-Maricich et al., 2011; Galabova-
Kovacs et al., 2008). Here, we have completely eliminated ERK/MAPK signaling by
deleting Mek1/2 and show that the generation of OPCs in the developing cortex is almost
completely blocked.
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MEK regulation of neurogenesis was not definitively addressed in this study due to
uncertainty about the timing of recombination in relation to the major phases of
neurogenesis which occur earlier than gliogenesis. A recent study showed a requirement for
ERK2 in regulating the proliferation of neurogenic precursors at E14, although results were
complex in that some layer markers showed depletion after Erk2 deletion but other layer
markers showed expansion (Pucilowska et al., 2012). Here, our data suggest prolonged
neurogenesis at late embryonic stages in Mek deleted cortices. Further, we demonstrate
fewer neurons, rather than more, in mature animals in the setting of Mek1 gain of function,
consistent with enhancement of gliogenesis at the expense of neurogenesis. Reconciliation
of these findings will require additional work with careful attention to timing of
recombination in neurogenic precursors.
Interestingly, the phenotype of Mek-deleted brains was somewhat more severe than in Erk-
deleted brains, an effect observed previously with other Cre lines (Newbern et al., 2008;
Newbern et al., 2011). Whether these differences relate to timing of the disappearance of
protein after Cre mediated recombination has yet to be determined. Although ERK is the
only well-established downstream substrate of MEK (Morandell et al., 2010), it is
interesting that a few studies outside the nervous system have reported kinase activity-
independent MEK functions that do not require ERK (Scholl et al., 2004; Wang et al.,
2009). Whether MEK may function independently of ERK in the mammalian brain remains
to be explored.
Mechanisms of MEK regulation of gliogenesis
We have found that the Ets family transcription factor Etv5/Erm is strongly regulated by
MEK. Erm is a member of the PEA3 subgroup which is comprised of Erm (Etv5), Er81
(Etv1) and Pea3 (Etv4). Ets transcription factors are well established as FGF targets and
have been reported to be phosphorylated and transactivated by the MAPK pathway
(Bertrand et al., 2003; Chen et al., 2005; Sharrocks, 2001). Several prior studies have
implicated Ets family members in regulation of gliogenesis. The Drosophila gene pointed,
which encodes an Ets transcription factor, is critical for directing glial differentiation in the
developing CNS of Drosophila (Jacobs, 2000; Klaes et al., 1994). Indeed a recent study has
demonstrated an important role for a FGF-Rolled (Drosophila MAPK)-Pointed signaling
cascade in inducing glia differentiation in the Drosophila eye (Franzdottir et al., 2009). In
Xenopus, both loss and gain of function studies demonstrated that RAS-MAPK signaling
acts through Xenopus Ets-1 to regulate radial glia development (Kiyota et al., 2007). In the
mammalian PNS, Erm has been implicated in glial cell fate decisions of neural crest
progenitors (Hagedorn et al., 2000). Although a previous study of Erm null mice found no
gross abnormality in the brain, the glial population was not assessed (Chen et al., 2005). As
all three PEA3 subgroup members are expressed in progenitors and their sequences are
highly homologous (Hasegawa et al., 2004), loss of one family member may not have a
drastic effect in vivo. However, our data clearly demonstrate that MEK specifically
regulates Erm expression in radial progenitors, that Erm overexpression in radial progenitors
is instructive in inducing glial progenitor specification and astrocyte differentiation, and that
Erm introduction into Mek-deleted radial progenitors ex vivo can restore CNTF-induced
astrogenesis.
Additional mechanisms are likely to be at play. Another strongly regulated transcription
factor is CoupTF-II (Table1). COUP TFs have previously been implicated in the neurogenic
to gliogenic fate transition (Naka et al., 2008). Further, we found Egfr expression is strongly
modulated by MEK signaling (Table 1). EGFR has been shown to increase its expression
during late cortical development and promotes progenitor gliogenic competence (Viti et al.,
2003). Finally, it is highly likely that MEK acts through epigenetic mechanisms to regulate
transcription of multiple genes related to glial differentiation. Indeed a prior study strongly
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implicated modulation of H3 methylation as an important mechanism of FGF signaling in
the cell fate switch that allowed glial differentiation (Song and Ghosh, 2004). Analysis of
epigenetic regulation will be an important area for future investigation.
Importance of findings for neurodevelopmental disorders
Importantly, gliogenesis has been assessed in detail in mouse models of human syndromes
due to RAF/MEK/ERK cascade overactivation. Work in a mouse model of
neurofibromatosis type1 (NF1) has shown a dramatic increase in brain gliogenesis and
decreased neurogenesis (Hegedus et al., 2007), findings that are very much in line with the
results reported here. A study using a Costello syndrome H-RAS active mutant construct
also showed a similar phenotype (Paquin et al., 2009). In both of these syndromes, gene
mutations lead to overactivation of RAF/MEK/ERK signaling and the phenotypes are
entirely consistent with our findings.
Another RAS/MAPK syndrome, Noonan’s syndrome, typically results from mutations in
SHP-2, an upstream modifier of the RAF/MEK/ERK cascade. Our results are not in line
with the concept that a SHP-2-MEK/ERK cascade is essential for neurogenesis and
suppresses gliogenesis as has been reported previously (Gauthier et al., 2007; Ke et al.,
2007). Although reasons for these differing interpretations are not entirely clear, it is
important to note that SHP-2 regulates several signaling cascades in addition to the RAS-
MAPK pathway. Additional effects of SHP-2 regulation include activation of PI3K-AKT
pathway and inactivation of JAK-STAT3 pathway (Coskun et al., 2007; Feng, 2007; Neel et
al., 2003). Thus, the reported effects in Shp-2 deficient animals may be due to abnormalities
in several pathways. Whatever the explanation for divergent results related to SHP-2, our
results are definitive as to the gliogenic functions mediated by MEK.
Importance of regulation of glial number in the postnatal brain
Astrocytes are thought to have critical functions in the postnatal brain related to neuronal
support and synaptic function. However, few prior studies have produced brains where
astrocyte number has been dramatically reduced during development. We have defined
several important in vivo consequences of regulating glial number in our study. First, we
noticed that Mek1,2\Nes mice are acallosal due to absence of midline astroglia.
Interestingly, the Fgfr1f/f;NesCre conditional mutant shows a similar phenotype. FGFR1 is
highly enriched in the telencephalic midline and is required for targeting specific groups of
radial glia to dorsal midline to form the indusium gresium, an important structure for axon
guidance (Smith et al., 2006).
Second, Mek1,2\hGFAP conditional nulls that survive through the first postnatal week
display a dorsal cortex which is almost completely devoid of astrocytes and exhibit a major
neurodegeneration phenotype. Although both neurons and glia lack MEK in these mice,
results from neuron specific Mek deleted mice suggest that neurons can survive into
adulthood in the absence of MEK (data not shown), indicating the degeneration in
Mek1,2\hGFAP dorsal cortices is likely due to the lack of glial support. A similar situation
holds in the periphery where MEK/ERK signaling is required for Schwann cell development
and neurons deprived of Schwann cell support die massively during embryonic development
(Newbern et al., 2011). Finally, subcortical dopamine neuron survival has also been shown
to be critically dependent on the astrocyte derived trophic factors-conserved dopamine
neurotrophic factor (CDNF) and mesencephalic astrocyte-derived neurotrophic factor
(MANF) (Lindholm et al., 2007; Petrova et al., 2003). The nature of glial-derived survival
signals for cortical neurons remains to be determined and should be a rich area for future
investigation.
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It is important to note that postnatal regulation is critical to establishing the number of
astrocytes and oligodendroglia in the mature CNS. It has long been known that proliferation
of OPCs postnatally is regulated by PDGF (Fruttiger et al., 1999). Very recently it has been
demonstrated that mature-appearing astrocytes in upper cortical layers also proliferate in the
postnatal period (Ge et al., 2012). Further recent studies demonstrate that oligodendrocyte
proliferation in spinal cord is partially under ERK/MAPK control (Newbern et al., 2011) and
that constitutively active B-Raf can drive proliferation of spinal cord astrocyte precursors
(Tien et al., 2012). These results in combination with our results showing expansion of
astrocytes in mice expressing caMek1, all strongly suggest that postnatal stages of glial
development may also be regulated by MEK/ERK/MAPK signaling.
Lastly we note that astrocytes are now known to play critical roles in synapse formation,
elimination and function (Allen and Barres, 2005; Christopherson et al., 2005; Stevens et al.,
2007). However, the consequences of increasing astrocyte number for cortical neuronal
physiology and behavior are unknown. Our MEK hyperactivation model may provide a
unique approach to study the effects of changing the glia/neuron ratio on synapse formation
and neuronal activity. Such studies may facilitate our understanding of the role of glia in the
cognitive abnormalities observed in CFC syndrome patients.
Materials and Methods
Genetically modified mice
The Mek1f/f, Mek2−/−, Erk1−/, Erk2 f/f and CAG-loxpSTOPloxp-Mek1S218E,S222E (caMek1)
mouse lines and associated genotyping procedures have been previously described (Krenz et
al., 2008; Newbern et al., 2008) and see supplemental experimental procedures. All
laboratory animal experiments were conducted in accordance with NIH guidelines and were
approved by the UNC-Chapel Hill Institutional Animal Care and Use Committee.
In utero and postnatal electroporation
Mice were anesthetized using 2,2,2-Tribromoethanol (4mg/10g mouse) and embryos were
gently exposed. Plasmids mixed with fast green were then microinjected into the lateral
ventricle of embryos. Using 5mm paddle electrodes, embryos were electroporated with five,
50ms pulses at 30V with a 950ms interval and gently returned to the abdominal cavity. For
postnatal electroporation, 1–2 μl of plasmid DNA was injected into the lateral ventricle of
cryo-anesthetized pups and three, 100ms pulses at 100V with a 950 ms interval were
administered.
In situ hybridization and Immunohistochemistry
Experiments were carried out using standard procedures. Details and a full list of primary
antibodies are given in the Supplemental Experimental Procedures.
Cortical progenitor cultures
Methods associated cortical progenitor cultures and organotypic slice cultures are described
in further detail in the Supplemental Experimental Procedures.
Additional methodological detail regarding quantification methods, laboratory animals,
Brdu labeling, Western blotting, viral vector transduction and microarray analysis is
provided in Supplemental Experimental Procedures.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Radial glial properties are not maintained in the absence of Mek1/2
(A–B′) The expression of radial progenitor markers, RC2 and GLAST, is strongly reduced
in E17.5 Mek1,2\Nes mutant radial progenitors (n=3). In A–A′, scale bar=100μm. In B–B′,
scale bar=50 μm. (C–C′) Pax6 immunostaining of radial progenitor nuclei is not obviously
different between E17.5 Mek1,2\Nes and WT cortices. Scale bar=100 μm. (D–D′) EGFP
labeled radial progenitors at E18 after in utero electroporation of pCAG-EGFP into E16.5
Mek1,2\Nes and WT dorsal cortices. Radial progenitors in Mek1,2\Nes animals exhibited a
normal morphological appearance. See also Figure S1.
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Figure 2. Mek1/2 deletion disrupts glial progenitor specification
(A–A′) Expression of Tenascin C, a glycoprotein secreted by astrocyte precursor cells, is
strongly reduced in the E18.5 Mek1,2\Nes cortex. (B–B′) BLBP immunostaining revealed a
dramatic reduction in astrocyte precursor number in mutant cortex. Scale bar=100 μm. (C–C
′) High magnification images of BLBP+ cells from delineated areas in B and B′. BLBP+
cell somas, which represent astrocytes precursors, were nearly absent in the mutant cortex at
P0. Scale bars=50μm. (n=3). (D–E′) The numbers of Olig2+ and PDGFRα+
oligodendrocyte progenitor cells are profoundly reduced in the E19.5 mutant dorsal cortex.
(n=3). Scale bar=100μm. (F) Western blotting confirms reduced Aldh1l1 and Acsbg1
expression in Mek1,2\Nes dorsal cortex compared to WT. 1 and 2 indicate duplicate protein
samples. (mean ± s.e.m; ** = p-value < 0.01, paired t-test). (G) Microarray analysis shows
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dramatic reductions of mRNAs expressed specifically in glial progenitors in Mek1,2\Nes
dorsal cortex, while expression of the neuronal genes shown was not altered. See also Figure
S2.
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Figure 3. Mosaic analysis of Mek gain of function in glial progenitor specification
(A–B) E15.5 dorsal cortices were electroporated with EGFP (A) or caMek1-EGFP (B) and
subsequently immunostained with BLBP to label astrocyte precursors at E19.5 (arrow head).
Scale bar=50μm. (C) Quantification showed that 5.7% of EGFP transfected cells are
BLBP+, while overexpression of caMek1 significantly increased the proportion of BLBP co-
labeled cells to 24.8% (mean ± s.e.m; ** = p-value < 0.01, paired t-test). N=400–500
transfected cells from three independent trials. Arrowheads indicate BLBP+ transfected
cells. (D–E) Overexpression of caMek1 in E15.5 radial progenitors induced formation of
large numbers of mature astrocytes in P60 dorsal cortices (E), while no astrocytes were
labeled in EGFP electroporated cortices (D). Arrowheads indicate astrocytes that express
caMek1. Scale bar=100μm. n=5. See also Figure S3.
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Figure 4. Gliogenic signaling is impaired in Mek1/2 deleted progenitor cultures
(A) Representative images of cortical progenitor cultures derived from the E17.5
Mek1,2\Nes mutant and WT dorsal cortices. Cultures were stimulated with CNTF for 5 days
and immunolabeled for GFAP (red) and Draq5 (blue). CNTF did not induce substantial
levels of astrocyte differentiation in mutant cultures. Scale bar= 50um. (B) Quantification of
the percentage of GFAP+ cells after 5 days of culture (mean ± s.e.m; n=4(>500 cells); ** =
p-value < 0.01, paired t-test). (C) Upper panel: Western blotting revealed strong reductions
in GFAP expression, while expression of the neural marker, βIII-tubulin, was not affected in
mutant cultures when compared to WT. Progenitors were cultured for 3 days with CNTF as
indicated. Lower panel: Further analysis of CNTF stimulated progenitor cultures by Western
blotting demonstrated that gp130 expression and phosphorylated STAT3 levels in E17.5
Mek1,2\Nes mutant culture were profoundly reduced when compared to WT. Progenitors
were cultured for 3 days prior to treatment with CNTF for 15 minutes as indicated. (D)
Quantification for levels of GFAP, βIII-tubulin, gp130 and pSTAT3 in (C). (Mean ± s.e.m;
n=3; ** = p-value < 0.01; n.s.: not statistically significant; paired t-test).
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Figure 5. Erm promotes glial progenitor specification and rescues gliogenesis of Mek deleted
progenitors in vitro
(A) Microarray analysis of E18.5 WT and Mek1,2\Nes mutant cortices showed that Etv5
(Erm) mRNA expression was strongly reduced in mutants, while other Ets family members
were changed to a lesser extent. (B–B′) In situ hybridization revealed that Erm is
predominantly expressed in VZ of E14.5 WT cortex (arrows); however, Erm expression in
Mek1,2\Nes VZ was profoundly reduced. (C–C′) Erm is expressed broadly in E18.5 WT
dorsal cortex VZ (arrows), hippocampus, and deep cortical layers. In mutant brains, Erm
expression was dramatically downregulated in the VZ but not in deep cortical layers. (D–D
′) Overexpression of Erm-EGFP in E15.5 radial progenitors promoted a dramatic increase in
the number of mature astrocytes in postnatal day 22 dorsal cortices. D′ is the delineated
areas in D. Arrows in D′ indicate EGFP labeled astrocytes. (E–F) High magnification
Li et al. Page 22













images of the astrocyte from the delineated area in D′ that expresses Erm-EGFP and
Acsbg1. (G) The proportion of EGFP+ astrocytes as quantified in EGFP or Erm-EGFP
transfected cortices. (Mean ± s.e.m; ** = p-value < 0.01; paired t-test, n=4). (H–J)
Representative images showing electroporation of radial progenitors ex vivo at E14.5
followed by dissociation and CNTF stimulation for 5 days. Some WT progenitors
differentiated into astrocytes (arrows in H). However, EGFP transfected Mek1,2\Nes mutant
progenitors did not become astrocytes (I). Electroporation of Erm-EGFP into mutant
progenitors rescued astrocyte differentiation (arrows in J). Scale bar=100μm. (K–L) High
magnification images from delineated area in (J) clearly show that Erm-EGFP transfected
cells expressed GFAP. Scale bar= 20μm. (M) Quantification shows that in Erm transfected
mutant cultures, astrocyte number reached 60% that of the EGFP transfected WT cultures.
(Mean ± s.e.m; N=4. **=p value<0.01, paired t test). See also Figure S4.
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Figure 6. Disrupted midline astroglia and absence of corpus callosum in Mek1/2 deleted cortex
GFAP and L1 double immunostaining labels midline astroglial populations and the corpus
callosum in P0 WT and Mek1,2\Nes mutant cortices (n=5). Note that in mutants (B), axons
in the corpus callosum form Probst bundles, a hallmark of callosal agenesis. Arrows indicate
the indusium gresium (IG) and midline zipper glia (MZG) in WT cortex (A), which were
missing in Mek1,2\Nes mutant cortex (B). See also Figure S5.
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Figure 7. Deletion of Mek1/2 results in persistent disruption of gliogenesis
(A–B′) In the P10 mutant brain, the number of Acsbg1+ astrocytes and MBP+
oligodendrocytes in dorsal cortices were dramatically reduced. cc: corpus callosum. (C)
Mek1,2\hGFAP brains are smaller and appear transparent at P10. (D) Western blots
confirmed the dramatic reductions of Acsbg1 and MBP expression in Mek1,2\hGFAP dorsal
cortices. (E–G) EGFP was electroporated at P1 to follow maturation of radial progenitors in
control and Mek deleted animals. EGFP-expressing mature appearing astrocytes were
readily apparent in P8 WT dorsal cortices (arrows in E and F), F is the delineated area in E,
G is the delineated area in F. Scale bars=100 μm in E and F, 10 μm in G. (H–I) EGFP
transfected Mek1,2\hGFAP cortices. Note that no mature-appearing astrocytes are observed.
I is the delineated area in H. EGFP expressing cells remained close to SVZ and did not
exhibit typical astrocytic morphology (I). N=4. See also Figure S6.
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Figure 8. Overactivation of MEK leads to excessive gliogenesis and reduced neurogenesis
(A–A′) BLBP immunostaining showed a robust increase in astrocyte precursor numbers in
E19.5 caMek1\hGFAP dorsal cortices compared to WT. (B–B′) Acsbg1 immunostaining
showed a profound increase of astrocyte number in caMek1\hGFAP dorsal cortices
compared to WT. (C–C′) GFAP+ labeling is typically restricted to white matter (corpus
collosum) in WT at P40, while GFAP + cells fill the entire thickness of ca-Mek1\hGFAP
dorsal cortex. (D–D′) Higher magnification images of GFAP+ cells from delineated areas in
C and C′. (E–E′) Immunostaining of NeuN revealed a marked decrease of neuron number
in caMek1\hGFAP dorsal cortices. (F–H) Quantification showed a significant increase of
BLBP+ astrocytic precursor number in E19.5 caMek1\hGFAP dorsal cortices (F), a
profound increase in the number of Acsbg1+ astrocytes (G) and a dramatic reduction of
NeuN+ neuron in P40 caMek1\hGFAP dorsal cortices (H). n=3. Scale bars= 100 μm, except
in E–E′ it represents 50 μm. N=3. *=p value <0.05, **=p value <0.01, paired t test. See also
Figure S7.
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Table 1
Comparison of mRNA expression profile between WT and Mek1/2 deleted brain
Microarray assay of E18.5 WT and Mek1,2\Nes mutant dorsal cortices revealed strong reductions in markers
of radial, astrocyte and oligodendrocyte progenitors.
Gene Symbol Gene Name Fold changes
Radial glia markers
Fabp7(BLBP) fatty acid binding protein 7, brain −2.55
Slc1a3(GLAST) solute carrier family 1 (glial high affinity glutamate transporter), member 3 −2.88
Genes related to astrocyte development
EGFR epidermal growth factor receptor −2.36
Aldh1l1 aldehyde dehydrogenase 1 family, member L1 −2.72
Aldoc Aldolase C −2.88
Acsbg1 acyl-CoA synthetase bubblegum family member 1 −3.27
Tnc tenascin C −4.71
Genes related to oligodendrocyte
development
PDGFRα platelet derived growth factor receptor, alpha polypeptide −6.64
Olig1 oligodendrocyte transcription factor 1 −4.47
Olig2 oligodendrocyte transcription factor 2 −3.65
Transcription factors
Nr2f2 nuclear receptor subfamily 2, group F, member 2, Coup TFII −2.50
Etv5 Ets translocation variant 5, ERM −2.94
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